Kenneth Pugh BTG

Phoenixville, PA United States

Board Member

Consulting / Advisory

A board member of Prohibix and an independent consultant/advisor since 2017, Kenneth (Ken) Pugh previously worked six years with the biopharmaceutical and interventional medicine company BTG. He served the firm as vice president of commercial development from 2014 to 2017 and vice president of IO marketing from 2013 to 2014. His accomplishments include growing the company’s IO medical device division from $35 million to $140 million in three years and serving as general manager for Latin America, commercializing multiple BTG products. He built internal teams "from the ground up" and implemented strategic alliances with partners in Canada, US and Latin America.